198 related articles for article (PubMed ID: 14735184)
61. Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.
Köhne CH; Wils J; Lorenz M; Schöffski P; Voigtmann R; Bokemeyer C; Lutz M; Kleeberg C; Ridwelski K; Souchon R; El-Serafi M; Weiss U; Burkhard O; Rückle H; Lichnitser M; Langenbuch T; Scheithauer W; Baron B; Couvreur ML; Schmoll HJ;
J Clin Oncol; 2003 Oct; 21(20):3721-8. PubMed ID: 12963704
[TBL] [Abstract][Full Text] [Related]
62. A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.
Bleiberg H; Vandebroek A; Deleu I; Vergauwe P; Rezaei Kalantari H; D'Haens G; Paesmans M; Peeters M; Efira A; Humblet Y
Acta Gastroenterol Belg; 2012 Mar; 75(1):14-21. PubMed ID: 22567742
[TBL] [Abstract][Full Text] [Related]
63. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.
Sugarbaker PH; Jablonski KA
Ann Surg; 1995 Feb; 221(2):124-32. PubMed ID: 7857141
[TBL] [Abstract][Full Text] [Related]
64. A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial.
Glockzin G; Rochon J; Arnold D; Lang SA; Klebl F; Zeman F; Koller M; Schlitt HJ; Piso P
BMC Cancer; 2013 Feb; 13():67. PubMed ID: 23391248
[TBL] [Abstract][Full Text] [Related]
65. Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancer.
Machida N; Yoshino T; Boku N; Hironaka S; Onozawa Y; Fukutomi A; Yamazaki K; Yasui H; Taku K; Asaka M
Jpn J Clin Oncol; 2008 Oct; 38(10):689-94. PubMed ID: 18845522
[TBL] [Abstract][Full Text] [Related]
66. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
Yan TD; Chu F; Links M; Kam PC; Glenn D; Morris DL
Eur J Surg Oncol; 2006 Dec; 32(10):1119-24. PubMed ID: 16887321
[TBL] [Abstract][Full Text] [Related]
67. [Systemic treatment of peritoneal metastases].
Arnold D; Lordick F
Chirurg; 2007 Dec; 78(12):1117-22. PubMed ID: 18004522
[TBL] [Abstract][Full Text] [Related]
68. A systematic overview of chemotherapy effects in colorectal cancer.
Ragnhammar P; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
[TBL] [Abstract][Full Text] [Related]
69. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
Sobrero A; Guglielmi A; Cirillo M; Recaldin E; Frassineti GL; Aschele C; Ravaioli A; Testore P; Caroti C; Gallo L; Pessi MA; Cortesi E; Turci D; Grossi F; Labianca R
Br J Cancer; 2001 Apr; 84(8):1023-8. PubMed ID: 11308248
[TBL] [Abstract][Full Text] [Related]
70. Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: a multicenter phase II study by the Cancer Therapeutic Research Group.
Ho WM; Ma B; Mok T; Yeo W; Lai P; Lim R; Koh J; Wong YY; King A; Leow CK; Chan AT
Med Oncol; 2005; 22(3):303-12. PubMed ID: 16110141
[TBL] [Abstract][Full Text] [Related]
71. [Methotrexate/5-fluorouracil therapy in gastric cancer with peritoneal metastasis].
Kosaka T; Sugaya J; Sejima T; Takano Y; Nakano Y; Akiyama T; Kiriyama M; Tomita F; Saito H; Kita I
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2266-9. PubMed ID: 7944456
[TBL] [Abstract][Full Text] [Related]
72. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
[TBL] [Abstract][Full Text] [Related]
73. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
[TBL] [Abstract][Full Text] [Related]
74. Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil.
Guglielmi A; Barni S; Zaniboni A; Pella N; Belvedere O; Beretta GD; Grossi F; Frontini L; Puglisi F; Labianca R; Sobrero A;
Br J Cancer; 2004 Oct; 91(8):1428-33. PubMed ID: 15381935
[TBL] [Abstract][Full Text] [Related]
75. Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG.
Taibi A; Lo Dico R; Kaci R; Naneix AL; Mathonnet M; Pocard M
Surg Oncol; 2020 Jun; 33():158-163. PubMed ID: 32561082
[TBL] [Abstract][Full Text] [Related]
76. Surgery as adjuvant therapy? The treatment of peritoneal metastases from gastrointestinal malignancy.
Lowy AM
Ann Surg Oncol; 2001 Dec; 8(10):754-5. PubMed ID: 11776486
[No Abstract] [Full Text] [Related]
77. Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR).
Maindrault-Goebel F; de Gramont A; Louvet C; André T; Carola E; Gilles V; Lotz JP; Tournigand C; Mabro M; Molitor JL; Artru P; Izrael V; Krulik M
Ann Oncol; 2000 Nov; 11(11):1477-83. PubMed ID: 11142489
[TBL] [Abstract][Full Text] [Related]
78. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.
Giacchetti S; Itzhaki M; Gruia G; Adam R; Zidani R; Kunstlinger F; Brienza S; Alafaci E; Bertheault-Cvitkovic F; Jasmin C; Reynes M; Bismuth H; Misset JL; Lévi F
Ann Oncol; 1999 Jun; 10(6):663-9. PubMed ID: 10442188
[TBL] [Abstract][Full Text] [Related]
79. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy.
Aschele C; Debernardis D; Lonardi S; Bandelloni R; Casazza S; Monfardini S; Gallo L
J Clin Oncol; 2004 Sep; 22(18):3758-65. PubMed ID: 15365072
[TBL] [Abstract][Full Text] [Related]
80. High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).
Maindrault-Goebel F; de Gramont A; Louvet C; André T; Carola E; Mabro M; Artru P; Gilles V; Lotz JP; Izrael V; Krulik M;
Eur J Cancer; 2001 May; 37(8):1000-5. PubMed ID: 11334725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]